Profile
Evren Alici is the founder of Fuse Biotherapeutics, Inc. He is currently the Chairman and CEO of Vycellix, Inc. and VyGen-Bio, Inc.
Evren Alici active positions
Companies | Position | Start |
---|---|---|
Vycellix, Inc.
Vycellix, Inc. BiotechnologyHealth Technology Vycellix, Inc. is a life science company that specializes in the development of cell and gene-based therapies for various medical conditions such as hematology/oncology, autoimmunity/chronic inflammatory diseases, and organ/tissue transplantation. The private company is based in Tampa, FL. The company's platforms were discovered by scientists at the Karolinska Institutet in Sweden, which is known for its Nobel Assembly. Vycellix is headquartered in the United States, with scientific operations in Sweden. The company's mission is to develop and commercialize optimized, next-generation T cell and natural killer (NK) cell-based cancer therapies using its transformational Vy-UC universal cell technology. The CEO of the company is Evren Alici. | Chief Executive Officer | - |
VyGen-Bio, Inc.
VyGen-Bio, Inc. BiotechnologyHealth Technology Part of Coeptis Therapeutics Holdings, Inc., VyGen-Bio, Inc. develops cell and gene therapies and treatments for cancer. The company is based in Tampa, FL. The CEO of the company is Evren Alici. VyGen-Bio was acquired by Coeptis Therapeutics Holdings, Inc. | Chief Executive Officer | - |
Former positions of Evren Alici
Companies | Position | End |
---|---|---|
Fuse Biotherapeutics, Inc.
Fuse Biotherapeutics, Inc. BiotechnologyHealth Technology Fuse Biotherapeutics, Inc. is a biotechnology company based in Los Angeles, CA. Fuse Biotherapeutics is dedicated to developing transformative immune modulating therapeutics for patients with cancer. The company's therapeutic approach integrates the multiple steps of an immune response in a rational manner that targets potent responses to danger without sacrificing natural breaks in the system that spare healthy tissues. The company was founded by Jeffrey Kunio Takimoto, Geoffrey W. Smith, Y Song Paul, Evren Alici, Brian Rabinovich. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Fuse Biotherapeutics, Inc.
Fuse Biotherapeutics, Inc. BiotechnologyHealth Technology Fuse Biotherapeutics, Inc. is a biotechnology company based in Los Angeles, CA. Fuse Biotherapeutics is dedicated to developing transformative immune modulating therapeutics for patients with cancer. The company's therapeutic approach integrates the multiple steps of an immune response in a rational manner that targets potent responses to danger without sacrificing natural breaks in the system that spare healthy tissues. The company was founded by Jeffrey Kunio Takimoto, Geoffrey W. Smith, Y Song Paul, Evren Alici, Brian Rabinovich. | Health Technology |
Vycellix, Inc.
Vycellix, Inc. BiotechnologyHealth Technology Vycellix, Inc. is a life science company that specializes in the development of cell and gene-based therapies for various medical conditions such as hematology/oncology, autoimmunity/chronic inflammatory diseases, and organ/tissue transplantation. The private company is based in Tampa, FL. The company's platforms were discovered by scientists at the Karolinska Institutet in Sweden, which is known for its Nobel Assembly. Vycellix is headquartered in the United States, with scientific operations in Sweden. The company's mission is to develop and commercialize optimized, next-generation T cell and natural killer (NK) cell-based cancer therapies using its transformational Vy-UC universal cell technology. The CEO of the company is Evren Alici. | Health Technology |
VyGen-Bio, Inc.
VyGen-Bio, Inc. BiotechnologyHealth Technology Part of Coeptis Therapeutics Holdings, Inc., VyGen-Bio, Inc. develops cell and gene therapies and treatments for cancer. The company is based in Tampa, FL. The CEO of the company is Evren Alici. VyGen-Bio was acquired by Coeptis Therapeutics Holdings, Inc. | Health Technology |
- Stock Market
- Insiders
- Evren Alici